ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

Annual Report Finds Cancer Incidence And Death Rates Fell For First Time.

December 5, 2008

DePinho Will Not Meet With AAUP In Probe of Tenure Denial Dispute

September 19, 2014

Piedmont, Mid-Atlantic Organizations Win Competition for NCI Support Of New Regional Cooperative Groups

April 16, 1982

ACCC Presentations On Care In Community

March 27, 1981

Eight Scientists Receive $800,000 From Milken

January 5, 1990